Sanofi adopts TriNetX platform to speed clinical trials

TriNetX has announced that it will be assisting Sanofi by using patient EHRs to optimize recruitment, streamline trial investigators’ workflows and otherwise impact the design of investigational drug trials. Sanofi has made similar arrangements to bolster its clinical trials with Science 37 and Evidation in March and July of last year, respectively.

The goal of the partnership is to simplify and to make better, earlier and more informed decisions. Sanofi has fully implemented the TriNetX technology across its entire portfolio last January.

Cambridge, MA based TriNetX operates a cloud-accessible federated health research platform.